Researchers have revealed how polymyxins, crucial last-resort antibiotics, break down bacterial armor by forcing cells to ...
In this free webinar, gain insights into how to improve recombinant protein expression through gene design, host selection ...
The biotechnology company reported that a drug meant to treat the skin condition hidradenitis suppurativa, or HS, didn’t have ...
Are you prepared to live a longer and healthier life? Discover practical ways to improve wellness, extend longevity, and embrace habits that support vitality every day.
At least 85 prominent scientists working in the US have moved full-time to Chinese research institutions since early 2024 ...
Preamble: In an era marked by geopolitical fragmentation, technological disruption, and climate urgency, trade policy must ...
Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic ...
Louise Hellem, Chief Economist at the CBI, discusses the Chancellor's options ahead of the U.K. government's upcoming Budget at the Labour Party Conference in Liverpool.
“With the Budget on the horizon, businesses will welcome the Chancellor’s clear intent to tackle the UK’s economic challenges head-on and put investment at the heart of future growth.
Industry representatives have voiced their support for the Biotech Act, hoping it will improve financing and institutional support of IVD makers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback